FDA.reportPublic FDA data

Nuclear matrix protein 22 IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of nuclear matrix protein 22 in a clinical specimen.
GUDID devices
2
Last updated
2023-09-14 08:46:09

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
10811877010606Alere NMP22 BladderChek Control Kit Alere Scarborough, Inc.D12502014-09-01
00811877011552NMP22 BladderChek Control KitAlere Scarborough, Inc.D12502022-08-08